(1)
Shapoval, O. S.; Vorontsova, L. L. Pathogenetic Rationale for the Use of Immunomodulating and Systemic Enzyme Therapy in Treatment of Nulliparous Women With Endometrioid Ovary Tumors. J Educ Health Sport 2015, 5, 75-86.